Condition: Systemic Lupus Erythematosus · Sponsor: Viatris Innovation GmbH
The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group | Anniston, Alabama, United States | — |
| University of California San Diego | La Jolla, California, United States | — |
| Valerius Medical Group and Research Center | Los Alamitos, California, United States | — |
| University of Colorado School of Medicine | Aurora, Colorado, United States | — |
| Robert W Levin MD PA | Clearwater, Florida, United States | — |
| Center for Rheumatology Immunology and Arthritis | Fort Lauderdale, Florida, United States | — |
| Life Clinical Trials | Margate, Florida, United States | — |
| D&H National Research Centers INC | Miami, Florida, United States | — |
| San Marcus Research Clinic | Miami Lakes, Florida, United States | — |
| Millennium Research | Ormond Beach, Florida, United States | — |
| Integral Rheumatology & Immunology Specialists | Plantation, Florida, United States | — |
| Advanced Research Institute Inc Allergy & Rheumatology | St. Petersburg, Florida, United States | — |
+ 136 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.